Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001641172-25-013418
Filing Date
2025-06-03
Accepted
2025-06-03 15:05:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 form424b5.htm 424B5 572205
2 GRAPHIC form424b5_001.jpg GRAPHIC 4373
3 GRAPHIC form424b5_002.jpg GRAPHIC 7922
  Complete submission text file 0001641172-25-013418.txt   590464
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269100 | Film No.: 251018890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)